Jiangxi Beike Xiehe Biotechnology Co., Ltd. is a representative high-tech enterprise of strategic emerging industries in Nanchang City, Jiangxi Province. It is dedicated to basic research and translational research in biomedical technology, striving to build a technology innovation system with enterprises as the main body, market-oriented, and integrating industry, academia, and research, to promote the industrialization of biomedicine. It has an integrated industry-academia-research system covering in vitro experiments, animal models, preclinical research, and translational research. Through continuous R&D and innovation in stem cell technology, immune cell technology, genetic engineering, and other fields, it provides patients with advanced biomedical technology services, using technology to improve human health.
Beike Group is committed to becoming a leading enterprise in promoting the clinical translation of biomedical technology, making unremitting efforts to improve human health.
Strong R&D strength: It has applied for more than 40 patents in the stem cell field, with 20 authorized; published nearly 100 papers in well-known international journals including Cell Stem Cell; undertaken more than 40 government projects at all levels, including 3 national-level projects (1 863 Program project), and in 2009 passed the national high-tech enterprise certification and obtained membership of the International Society for Cellular Therapy (ISCT).
Strict quality control system: Beike Biotechnology has always adhered to a rigorous quality management system and professional conduct:
The first enterprise in China's stem cell field to simultaneously obtain ISO9001, ISO14001, and OHSA18001 quality management system certifications;
The first member unit in China recognized by the International Society for Cellular Therapy (ISCT), marking that the quality standards of mesenchymal stem cells (MSC) prepared by Beike have reached international standards, and the MSC therapy approved by the US FDA also adopts the same standard;
The first laboratory in China's stem cell field to obtain CNAS ISO17025 accreditation;
The first cord blood stem cell bank in mainland China to obtain AABB accreditation;
The world's first batch of umbilical cord mesenchymal stem cell banks to obtain AABB accreditation;
The first stem cell bank in mainland China to obtain AABB on-site re-accreditation
Vast global clinical translational research technical support network: It has provided cell therapy clinical translational research technical support to more than 70 medical institutions across the country and many countries in Southeast Asia, the Middle East, Europe, etc., accumulating the world's largest-scale and most comprehensive database on the safety and efficacy of somatic cell clinical research.
Asia's largest comprehensive stem cell bank group: The first-phase stem cell bank group includes Jiangsu Stem Cell Bank, Shenzhen Stem Cell Bank, and Anhui Stem Cell Bank, with a total construction area of 30,000 M2, a total designed storage capacity of more than 2 million units, and a total investment of nearly 500 million yuan. The second-phase construction includes Liaoning Stem Cell Bank, Henan Stem Cell Bank, Guizhou Stem Cell Bank, India Stem Cell Bank, and Thailand Stem Cell Bank. After completion, the total designed storage capacity will approach 10 million units.
Beike Biotechnology will uphold the corporate philosophy of "rigorousness, innovation, care, and service" to promote cell technology for the benefit of human health with unremitting pursuit.
Every employee is the most valuable asset of the enterprise. We emphasize respect for employees, respect their knowledge, skills, and individuality, and strive to create an environment where employees can contribute to the enterprise while achieving personal development and value enhancement.
In selecting, cultivating, employing, and retaining people, we emphasize both integrity and ability. Good professional ethics and superb technical capabilities are equally important.
The cause we are engaged in is at the forefront of today's biotechnology development, requiring us to always grasp the pulse of technological development, and the rehabilitation health industry requires every employee to possess the qualities of meticulousness, carefulness, and compassion.
In employment, we do not only value academic qualifications but focus on actual talent and quality. Learning and self-learning ability are key evaluation items for us.
We welcome and look forward to individuals who aspire to "benefit human health with biotechnology" joining our team to jointly develop this cause of great significance to human health.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows